This study was supported by a NARSAD Young Investigator award (MCC), the Greater St Louis Chapter of the American Parkinson Disease Association (APDA), NIH (NS41509; NS54353; NS058797; K24 MH087913), NCRR (UL1 RR024992), the Neuroscience Blueprint Grant at Washington University (P30 NS057105), APDA Advanced Center for PD Research at Washington University, McDonnell Center for Higher Brain Function, and the Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund, the Handelman Fund, and Jack Buck Fund for PD Research).
Dr. Campbell receives salary and research support from NIH, NARSAD, McDonnell Foundation, American Parkinson Disease Association (APDA), and the Greater St Louis Chapter of the APDA.
Dr. Black receives salary and research support from NIH and Tourette Syndrome Association. He has consulted for Gerson Lehman Group, Corregidor, and Merck. He is an inventor on a patent in prosecution (#11/583,896), U. S. patent pending, “Novel methods for medicinal dosage determination and diagnosis,” inventors Kevin J. Black and Jonathan M. Koller.
Mr. Weaver receives salary support from NIH.
Ms. Lugar receives salary support from NIH.
Dr. Videen receives salary and research support from NIH and the Michael J. Fox Foundation.
Dr. Tabbal receives salary and research support from NIH.
Dr. Karimi receives salary and research support from NIH. Dr. Karimi previously received partial fellowship funding from Medtronic, Inc., the manufacturer of the implanted stimulators. Dr. Perlmutter receives salary and research support from NIH, Cure Huntington Disease Initiative, American Parkinson Disease Association, Greater St Louis Chapter of the APDA, McDonnell Foundation, Barnes-Jewish Hospital Foundation, Wash. University, Huntington's Disease Society of America, Michael J. Fox Foundation, Express Scripts, and the Bander Foundation for Medical Business Ethics; NIH subcontracts via Emory and the University of Rochester. Honoraria: Toronto Western Hospital, University of Maryland, University of Saskatoon, Parkinson Study Group (University of Rochester), Society of Nuclear Medicine, Movement Disorders Society, Bachmann Strauss Foundation and American Academy of Neurology. He is on the Dystonia Medical Research Foundation and APDA advisory boards.
Dr. Hershey receives salary and research support from NIH. She has received honoraria from NIH and from the journal Diabetic Hypoglycemia. She is on the Tourette Syndrome Association scientific advisory board.